Moon surgical. Enabled by NVIDIA Holoscan, a real .
- Moon surgical. Mar 18, 2025 · Moon Surgical, a French-American pioneer in surgical innovation, announced today it is expanding its long-standing collaboration with NVIDIA to further advance the Maestro System's Physical AI Moon Surgical | 23,982 followers on LinkedIn. We believe the team is the Jun 15, 2025 · Moon Surgical - About the company Moon Surgical is a series B company based in France, founded in 2020 by Brice Pretty. 7M over 2 rounds from 12 investors. We believe in setting ambitious yet attainable goals and overcoming challenges together, using each success as a launchpad for further exploration and innovation. Food and Drug Administration (FDA) to launch its futuristic laparoscopy robot. Sep 26, 2023 · Moon Surgical announced today that a hospital in Florida performed the first U. While also embracing humor, kindness, and understanding, all of which is reflected in our products. The Maestro System from Moon Surgical, Jul 2, 2025 · Moon Surgical today announced it received FDA 510(k) clearance for two new features on the Maestro robotic surgical assistant. Moon Surgical has announced that the latest version of its Maestro System is CE Marked under the Medical Device Regulation (EU) 2017/745. Information on valuation, funding, cap tables, investors, and executives for Moon Surgical. R. Jun 25, 2025 · Moon said its platform has supported procedures in 60 different types of minimally invasive surgeries, demonstrating its adaptability across specialties. 4 Jan 9, 2025 · Moon Surgical, a pioneer in laparoscopic surgical innovation, today announced the first 20 patients successfully treated at an Ambulatory Surgery Center (ASC) using the Maestro™ digital surgical Moon Surgical has announced its participation at NVIDIA GTC Paris during VivaTech2025. Successful sleeve gastrectomies were performed using the Maestro Robot at Baptist Health in Jacksonville, Florida. Food and Drug Administration (FDA) for two major advancements to its Maestro System: connectivity of the platform to power the Maestro Dec 1, 2023 · Moon Surgical CEO Anne Osdoit on readying a soft tissue robot for launch With support from J&J’s venture capital arm and chip maker Nvidia, Moon is targeting a soft tissue surgery market dominated by Intuitive Surgical. 4m in venture funding co-led by Sofinnova Partners, through its Sofinnova Capital Strategy, and NVIDIA’s venture capital arm, NVentures. It is a privately held portfolio company of Sofinnova Partners, financed through the MD Start III Fund. In September 2023, Maestro was used to assist in weight loss surgery procedures in the US. Jun 19, 2025 · Moon Surgical's Maestro system provides surgeons with robotic "extra hands" during soft tissue procedures, aiming to enhance efficiency and autonomy while enabling surgical staff to focus on higher-level tasks. moonsurgical. 7M in funding from investors like GT Healthcare Capital Partners, Sofinnova Partners and nVentures. Moon Surgical is a medical device company developing a surgical robot for laparoscopy assistance. 2 days ago · See Moon Surgical valuation, funding & investors. Nov 13, 2024 · At Moon Surgical, patient safety is our top priority Our cyber-security team works tirelessly to keep our medical technologies safe and secure. MastOR is an early-stage surgical robotics company whose laparoscopy assistance platform broadens access to minimally-invasive techniques for surgeons and optimizes resource utilization in the operating room. Jun 6, 2024 · Moon Surgical has received clearance from the US Food and Drug Administration (FDA) for the commercial version of its Maestro surgical system. Jun 12, 2025 · Moon Surgical, the French-American leader in Physical AI for the operating room, today announced its participation at NVIDIA GTC Paris during VivaTech2025. Moon Surgical appoints Fred Moll as Board Chair and raises $55. Jun 5, 2024 · Moon Surgical has received approval from the U. Enabled by NVIDIA Holoscan, a real May 29, 2025 · Moon Surgical Scopilot Authors: Katerina Jou, MD, David Pechman, MD Moon Surgical, a French-American surgical technology-focused company, received FDA clearance for ScoPilot™ on March 18, 2025. Maestro delivers surgical and O. Mar 18, 2025 · Moon Surgical received FDA clearance for ScoPilot, a platform that uses Nvidia Holoscan to improve laparoscopic surgery. Connect with the world's best brokers to learn how to buy Moon Surgical stock today. At Moon Surgical we are pioneering the future of Minimally Invasive Surgery Delivering the benefits of surgical robotics while preserving the existing surgical workflow, technics and Oct 31, 2024 · We are excited to announce that Moon Surgical has successfully raised $55 million in a recent funding round, a significant milestone that will propel our mission to revolutionize the surgical landscape. Le système robotique chirurgical Maestro de la start-up Moon Surgical vient d'obtenir l’autorisation de la Food and Drug Administration (FDA) des États-Unis. The company said it will now begin deploying its surgical assistant in the U. Moon Surgical has raised $86. Food and Drug Administration (FDA) for two major advancements to its Maestro Jun 12, 2025 · PARIS and SAN FRANCISCO, June 12, 2025 /PRNewswire/ -- Moon Surgical, the French-American leader in Physical AI for the operating room, today announced its participation at NVIDIA GTC Paris during The Moon Surgical Maestro device is an electrically actuated device with movable components intended for laparoscopic surgical procedures to support and position laparoscopic instruments. May 17, 2023 · With a fresh injection of venture funding and a high-profile addition to its board, Moon Surgical is entering a new phase. Dec 19, 2022 · Moon Surgical quickly cleared two development stages this month as it blasts toward its goal of providing laparoscopic surgeons with a robotic helper on the operating table. 4 million and appointed a surgical robotics veteran as the chair of its board. and European Union. 3m Series A funding completed in June 2022. We continuously monitor for any vulnerabilities and take swift action to address them, ensuring our patients and medical partners remain protected. Food and Drug Administration has granted clearance for the commercial version of its Maestro surgical robot. Jun 5, 2024 · Moon Surgical announced today that the U. The Maestro system aids operating room staff during soft tissue surgeries by holding instruments and cameras with two maneuverable robotic arms. 4 million in additional funding to support the continued development and planned Moon Surgical Profile and History MastOR SAS is a Paris-based, early stage medical device company, developing a surgical robot for laparoscopy assistance. Jul 2, 2025 · Read about Moon Surgical news regarding the latest FDA clearance for groundbreaking tech enhancing surgical precision and AI integration in healthcare. “We believe in this team’s capacity to bring Maestro to the market and revolutionize the surgical robotics landscape by combining their experience and insights in the needs of the surgeon, patient, and provider. The company, which has offices in Paris and San Francisco, also believes it can provide value in supporting high-volume outpatient care. Investors include Sofinnova Partners, Johnson & Johnson Innovation and 10 others. Learn about its values, story, team, partners, and achievements since its founding in 2020. May 21, 2023 · Moon Surgical recently raised $55. Jun 24, 2025 · Designed to enhance human expertise, Maestro supports surgical teams with adaptability, control, and efficient integration into existing workflows. At Moon Surgical we are pioneering the future of Minimally Invasive Surgery Delivering the benefits of surgical robotics while preserving the existing surgical workflow, technics and Dec 18, 2024 · Moon Surgical announced that it appointed medtech veteran Chris Toth as an independent member of its board of directors. Jul 4, 2023 · Moon Surgical développe et commercialise un robot d'assistance aux chirurgiens. in San Carlos, CA, such as Contacts, Addresses, Reviews, and Registered Agent. The financing, which had participation from Dr Fred Moll and Dr Josh Makower, will be used to develop the Paris, France-based company’s robotic . With over 20 years of experience in Jun 6, 2024 · Moon Surgical has received clearance from the US Food and Drug Administration (FDA) for the commercial version of its Maestro surgical system. Maestro, which received US Food and Drug Administration (FDA) clearance in December 2022, is designed to assist in traditional laparoscopic procedures. The core technology is derived from joint research between the ISIR robotics lab at Sorbonne University and Professor Brice Gayet, a Moon Surgical has the United States Food and Drug Administration (FDA) clearance for its unique Maestro surgical robotics system. Moon Surgical is a French-American company that develops and commercializes robotic surgery systems. Jun 5, 2024 · Moon Surgical , a French-American pioneer in surgical innovation, announced today the United States Food and Drug Administration (FDA) clearance for the commercial version of its unique Maestro surgical system. With simplicity and workflow integration at their core, they have designed a system that enhances existing laparoscopy techniques and tools with new capabilities, providing an unprecedented surgical experience. Moon Surgical has announced the United States Food and Drug Administration (FDA) clearance for the commercial version of its unique Maestro surgical system. Mar 18, 2025 · Moon Surgical announced today that it received FDA clearance for ScoPilot, a Nvidia-enabled platform for its Maestro surgical robot. “This new milestone is a testament to our team’s hard work and dedication, and attests to the effective ramp-up of our manufacturing and quality operations,” said Anne Osdoit, CEO of Moon Surgical, and a Partner in Sofinnova Partners’ medtech accelerator, MD Start May 17, 2023 · Moon Surgical announced today that it raised $55. Jun 7, 2022 · Moon Surgical will use the funding to expand its team in both France and the United States and accelerate the development of its Maestro Robotic System. As a pioneering company at the intersection of advanced technology and healthcare, Moon Surgical is dedicated to enhancing surgical procedures through cutting-edge innovations in computer I dive into the space between full blown surgical robotics and straight stick laparoscopy to the emerging field of advanced assisted laparoscopy with the Mae Sep 20, 2022 · Activ Surgical, Moon Surgical and Proximie will bring real-time AI to their surgery platforms using NVIDIA Clara Holoscan on NVIDIA IGX. Moon Surgical – Empowering the Surgeon Moon Surgical is creating an entirely new category of Robotic Surgery. Jun 5, 2024 · It’s all systems go for Moon Surgical with a new FDA green light for its Maestro robotic laparoscopy platform. It operates as a Provider of robotic surgical devices. 5 million for its robotic surgical assistant, which has earned regulatory clearance in the U. 4M on May 17, 2023 . The startup said the system can augment the precision and control of laparoscopic surgery. In collaboration with NVIDIA, Moon Surgical is highlighting the Maestro System as a pioneering example of Physical AI in action—empowering surgical teams across the globe. The system is the first of its kind for laparoscopic surgeries and can integrate into existing systems. Enabled by NVIDIA Holoscan, a real Jul 15, 2025 · /PRNewswire/ -- Moon Surgical, the leader in Physical AI for the operating room, today announced the successful launch of its Maestro™ Platform at Lee Health's Moon Surgical has announced that its Maestro System is now CE Marked under the Medical Device Regulation (EU) 2017/745. ScoPilot™ is the first intraoperative artificial intelligence platform that enables NVIDIA’s Holoscan to run locally on Moon Surgical’s Maestro™ system, the company’s robotic surgical May 17, 2023 · Moon Surgical, a French-American pioneer in collaborative robotics, announced today that it has secured $55. Their emphasis on surgical applications provides a competitive edge over general medical robotics Jan 9, 2025 · /PRNewswire/ -- Moon Surgical, a pioneer in laparoscopic surgical innovation, today announced the first 20 patients successfully treated at an Ambulatory Jun 25, 2025 · The challenger to Intuitive Surgical said its Maestro platform has aided in more than 1,600 surgeries to date, with the majority performed in the past year. operational insights to support surgeons and their teams deliver the best patient care. Moon Surgical develops robotic-assisted surgical systems within the healthcare industry. The company previously received FDA clearance for a non-commercial version of the system in September 2022. S. Mar 19, 2024 · Moon Surgical today announced that over 200 patients have been successfully treated with its Maestro System, powered by NVIDIA Holoscan, which delivers surgeon autonomy in its first commercial use Moon Surgical has announced that over 200 patients have been successfully treated with its Maestro System, powered by NVIDIA Holoscan, which delivers surgeon autonomy in its first commercial use in various surgical interventions. Sep 26, 2023 · Moon Surgical, a French-American pioneer in collaborative robotics, today announced that Baptist Health (Jacksonville, Florida) performed the first cl May 18, 2023 · Moon Surgical has secured $55. Mar 18, 2025 · Moon Surgical, based in Paris, France, and San Francisco, California, is building the OR of the future, one that is digitalized, efficient, and sustainable. Elle lève 51 millions d’euros. The funding adds to a previous $31. market with robotic surgery systems. Dec 17, 2024 · Moon Surgical, a pioneer in laparoscopic surgical innovation, today announced the appointment of Chris Toth as an independent member of its Board of Directors. Jun 12, 2024 · This month, Moon Surgical received FDA clearance for the commercial version of its Maestro surgical robot system. Empowering the Surgeon | Moon Surgical aims to augment the surgeon with leaps forward in computer vision, haptics, and robotics. Surgeon’s Point Surgery Center, located in Cedar Park, Texas, is the first ASC in the world to leverage the capabilities of the Maestro System. Moon Surgical (formerly known as MastOR) is a medical device company that develops a surgical robot for laparoscopy assistance. and Europe Moon Surgical receives FDA clearance for ScoPilot™ on Maestro, industry's first AI-enhanced intraoperative capability, powered by NVIDIA Holoscan Jun 5, 2024 · Moon Surgical announced today that it received FDA clearance for the commercial version of its Maestro surgical robot system. Moon Surgical is taking a different approach to robotics, returning the surgeon to the patient’s bedside, augmenting surgeons by giving them control over all of their instruments throughout the procedure. Use the PitchBook Platform to explore the full profile. Jan 29, 2025 · 4 robotic surgery trends to watch in 2025 Intuitive Surgical will face competition this year from Medtronic and smaller companies like CMR Surgical and Moon Surgical coming to the U. Jun 5, 2024 · Moon joins an expanding list of robot makers aiming to compete in a soft tissue surgery market led by Intuitive Surgical. Maestro's gravity-defying arms understand when to lock and unlock without you having to say it They are "light as a feather in movement, and sturdy as a rock in holding" Nov 14, 2023 · Moon Surgical tries to break down this barrier by using a business model which allows doctors to spend less time in operating rooms and more time helping to care for their patients. The system was designed to be more flexible and affordable than other currently-available robotic platforms. At Moon Surgical, we’re not just building innovative tools for the OR — we’re building a culture that celebrates collaboration, creativity, and a bit of friendly competition along the way. Moon Surgical. Mar 18, 2024 · View Moon Surgical (www. Dec 16, 2024 · At Moon Surgical, we build things that matter. The system is designed to support surgeons and other operating room staff Ready to welcome Maestro™ in your OR? Deploy Maestro today! Moon Surgical announced 510(k) clearance from the U. Moon Surgical said Moon Surgical announces the successful completion of 30 First-in-Human laparoscopy procedures using its Maestro System at CHU Saint-Pierre, a public university hospital in Brussels, Belgium. “At Moon Surgical, we are innovating and inspiring the art of surgery. Mar 19, 2025 · Moon Surgical宣布其ScoPilot获得美国食品药品监督管理局（FDA）的批准，这是首个在商用手术机器人平台上运行的AI应用，旨在提高手术过程中的控制、安全和效率。 Moon Surgical, based in Paris, offers a promising business proposition with its focus on robotic technology to enhance surgical procedures. With this clearance, Maestro Systems can now have active Wi-Fi and […] Jul 2, 2025 · Moon Surgical, today announced 510(k) clearance from the U. The startup also appointed Fred Moll, founder Jul 28, 2025 · Discover Company Info on MOON SURGICAL, INC. Mar 18, 2025 · Moon Surgical's commercial Maestro System, FDA-cleared in June 2024, has been used to treat over 1,100 patients across the United States and Europe, spanning general, bariatric, gynecologic, and urologic surgeries. clinical procedures with its Maestro surgical robot. The company Nov 10, 2023 · Moon Surgical, a robotics startup based in Paris and San Francisco, assisted in its first clinical procedure in the U. Mar 18, 2025 · Moon Surgical, a French-American pioneer in surgical innovation, announced today the United States Food and Drug Administration (FDA) clearance for ScoPilot. S Sep 27, 2023 · Surgeons in the US have used Moon Surgical’s Maestro system to aid weight loss surgery procedures, in what are the first-use cases of the robotic system in the country. Moon Surgical | LinkedInのフォロワー数24,326人。Empowering the Surgeon | Moon Surgical aims to augment the surgeon with leaps forward in computer vision, haptics, and robotics. About Moon Surgical Moon Surgical is transforming the operating room with Physical AI, seamlessly integrating intelligence and robotics to elevate the capabilities of surgical teams. Jul 2, 2025 · PARIS and SAN FRANCISCO, July 2, 2025 /PRNewswire/ -- Moon Surgical, today announced 510 (k) clearance from the U. Jun 26, 2025 · Moon Surgical this week announced it added three senior hires to its C-suite as the company accelerates the commercialization of its Maestro. Base, Surgical Arms, Control Unit, Instrument Coupling, and Control Station N/ Previous “Operating table” related codes are now all Class I 510(k) exempt. Moon Surgical — one of 10 surgical robotics companies Mar 18, 2025 · Founded in 2020, Moon Surgical prides itself on staying nimble, prioritizing innovation, and fostering inclusivity, creativity, and collaboration among its multi-cultural team members. ” Apr 12, 2023 · Moon Surgical, a French-American pioneer in collaborative robotics, announced today that its Maestro System is now CE Marked under the Medical Device Regulation (EU) 2017/745. Dec 6, 2022 · Moon Surgical, a French-American pioneer in accessible surgical innovation, announced today the United States Food and Drug Administration (FDA) clearance for its unique Maestro surgical robotics Moon Surgical | 24,338 followers on LinkedIn. Moon Surgical is transforming the operating room with Physical AI, seamlessly integrating intelligence and robotics to elevate the capabilities of surgical teams. Maestro Insights ™ consolidates procedural, OR environment data, and consumable usage information to streamline turnover and enhance hospital efficiency. Explore our latest achievements. In collaboration with NVIDIA, Moon Jun 23, 2025 · Moon Surgical Launches Maestro™ Platform at Lee Health Moon Surgical Expands Leadership Team to Accelerate Commercial Growth Across U. Food and Drug Administration (FDA) for two major advancements to its Maestro System: connectivity of the platform to power the Maestro Insights product and a Predetermined Change Control Plan (PCCP) to evolve its AI-powered ScoPilot product. Jun 5, 2024 · PARIS and SAN FRANCISCO, June 5th, 2024 -- Moon Surgical, a French-American pioneer in surgical innovation, announced today the United States Food and Drug Administration (FDA) clearance for the commercial version of its unique Maestro surgical system. With its unique and extensive ambient sensing, paired with NVIDIA-accelerated computing and AI, Maestro generates an unprecedented surgical dataset including multi-modal sensing and Mar 19, 2024 · Moon Surgical today announced that over 200 patients have been successfully treated with its Maestro System, powered by NVIDIA Holoscan, which delivers surgeon autonomy in its first commercial use in various surgical interventions. Jun 5, 2024 · Moon Surgical, a French-American company, has received FDA clearance for its Maestro System, a unique robotic surgery platform for laparoscopic procedures. Jun 15, 2025 · Moon Surgical has raised a total funding of $86. Moon Surgical ℅ Michael Daniel Consultant Daniel & Daniel Consulting June 3, 2024 Moon Surgical c/o Michael Daniel Consultant Daniel & Daniel Consulting 340 Jones Lane Gardnerville, Nevada 89460 Mar 18, 2025 · Moon Surgical, a French-American pioneer in surgical innovation, announced today the United States Food and Drug Administration (FDA) clearance for ScoPilot. 4 days ago · 510 (k) Premarket NotificationFDA Home Medical Devices Databases Moon Surgical has announced the first 20 patients successfully treated at an Ambulatory Surgery Center (ASC) using the Maestro™ digital surgical assistant. Find related and similar companies as well as employees by title and much more. Maestro, dont le prototype a été développé à l'ISIR, est destiné à la chirurgie mini-invasive, et sera commercialisé dès 2024 auprès des hôpitaux et des centres chirurgicaux américains. May 17, 2023 · Moon Surgical is a prime example,” commented Antoine Papiernik, Chairman, and Managing Partner of Sofinnova Partners. The company also collaborates with Nvidia Isaac for Healthcare to develop more intelligent capabilities on its Maestro system. 4 Million in new funding with leading investors Sofinnova Partners and NVIDIA. We are cohesive, focused, hardworking, and dedicated. Mar 18, 2025 · /PRNewswire/ -- Moon Surgical, a French-American pioneer in surgical innovation, announced today it is expanding its long-standing collaboration with NVIDIA to Moon Surgical develops a new category of robotic surgery that enhances existing clinical practice with collaborative and adaptive robotics. CEO Anne Osdoit spoke with MobiHealthNews about the company's robotic surgery technology Jul 24, 2015 · Moon Surgical developed the minimalistic Maestro system as a two-armed robotic surgical assistant that can aid a surgeon by holding or manipulating tissues in laparoscopic surgery. As a B2B solution, the company aims to disrupt traditional manual surgeries by improving precision, reducing errors, and shortening patient recovery times. Their latest funding round was of $55. The system is designed to enhance surgical efficiency, patient outcomes and data-driven insights with artificial intelligence. It offers Maestro, a digital assistant that gathers intraoperative data and delivers operating room (OR) operational insights to support surgeons, patient safety, etc. Last week, the Maestronauts came together to reflect on our momentum, celebrate recent wins, and kick off our first-ever bocce ball tournament (yes, things got competitive). The company's offerings include the Maestro System, a digital surgical assistant, and Maestro Insights, software that provides insights to healthcare professionals. The Fierce 15 honoree’s latest financing round clocked in at $55. com) location in California, United States , revenue, industry and description. hqnnr slbm dkxxl xtweh ywyogoe lgjzo dunk agn nmeupt eiodkyr